Impact of experience on visual behavior and driving performance of high-speed train drivers. [PDF]
Sci Rep, 2022 Du Y, Zhi JY, He SJ.
europepmc +1 more source
Nose Shape Optimization of High-speed Train for Minimization of Tunnel Sonic Boom.
, 2001 Hyeok-Bin Kwon +4 more
openalex +2 more sources
Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The aging population of people with HIV (PWH) raises heightened concerns regarding accelerated aging and dementia. Portable, low‐field MRI (LF‐MRI) is an innovative technology that could enhance access and facilitate routine monitoring of PWH.
Annabel Sorby‐Adams +14 more
wiley +1 more source
Simulation and Experimental of Infiltration and Solidification Process for Al2O3(3D)/5083Al Interpenetrating Phase Composite for High Speed Train Prepared by Low-Pressure Infiltration. [PDF]
Materials (Basel), 2023 Jiang Y +6 more
europepmc +1 more source
Development of High Speed Train Door System for Improving Maintenance
, 2019 Korea Railroad Corporation, Korea
openalex +1 more source
A deep learning framework for adaptive compressive sensing of high‐speed train vibration responses
, 2022 Si‐Xin Chen, Yi‐Qing Ni, Lu Zhou
openalex +2 more sources
Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan +22 more
wiley +1 more source
Vertical Suspension Optimization for a High-Speed Train with PSO Intelligent Method. [PDF]
Comput Intell Neurosci, 2021 Qiu Z, Han S, Na J, Wang C.
europepmc +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source